OKYO Pharma Limited (OKYO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 50.15M |
| Enterprise Value | 48.59M |
| P/E Ratio | -12.61 |
| PEG Ratio | 0.28 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -17.04 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.8 |
Fiscal Year
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.99 |
| Return On Equity | 1.03 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2,563 |
| EBITDA | -7.08M |
| Net Income | -4.71M |
| Diluted EPS | -0.12 |
Balance Sheet
| Total Cash | 4.22M |
| Total Cash/Share | 0.11 |
| Total Debt | 185,795 |
| Total Debt/Equity | -0.05 |
| Current Ratio | 0.58 |
| Book Value Per Share | -0.09 |
Price History
| 52-Week Change | -29.22 |
| 52-Week High | 3.35 |
| 52-Week Low | 1.42 |
| Moving Average 50 Days | 1.61 |
| Moving Average 200 Days | 1.94 |
Statistics
| Average Volume | 68,661 |
| Shares Outstanding | 38.37M |
| % Held by Institutions | 0.13 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
